Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody

[1]  A. Wilder-Smith,et al.  Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates , 2019, Vaccine.

[2]  E. Harris,et al.  Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas , 2018, The Journal of infectious diseases.

[3]  A. Barrett.  Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation , 2018, npj Vaccines.

[4]  Stephen J. Thomas,et al.  Zika vaccines and therapeutics: landscape analysis and challenges ahead , 2018, BMC Medicine.

[5]  J. Wrammert,et al.  Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity. , 2017, The Journal of infectious diseases.

[6]  P. Rijal,et al.  WHO collaborative study to assess the suitability of the 1st International Standard and the 1st International Reference Panel for antibodies to Ebola virus. WHO Expert Committee On Biological Standardization , 2017 .

[7]  S. Booth,et al.  Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice , 2017, Antiviral research.

[8]  S. Kushner,et al.  Phenotypic Differences between Asian and African Lineage Zika Viruses in Human Neural Progenitor Cells , 2017, mSphere.

[9]  F. Rovida,et al.  Antibody-based assay discriminates Zika virus infection from other flaviviruses , 2017, Proceedings of the National Academy of Sciences.

[10]  R. Hewson,et al.  Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice , 2017, PLoS neglected tropical diseases.

[11]  R. Albrecht,et al.  A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses , 2017, PLoS pathogens.

[12]  E. Lattwein,et al.  Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016 , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  L. Rodrigues,et al.  Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. , 2016, The Lancet. Infectious diseases.

[14]  FOURTH MEETING OF THE EMERGENCY COMMITTEE UNDER THE INTERNATIONAL HEALTH REGULATIONS (2005) REGARDING MICROCEPHALY, OTHER NEUROLOGICAL DISORDERS AND ZIKA VIRUS , 2016, Saudi Medical Journal.

[15]  J. Molès,et al.  Zika Virus Strains Potentially Display Different Infectious Profiles in Human Neural Cells , 2016, EBioMedicine.

[16]  J. Mascola,et al.  Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. , 2016, Cell reports.

[17]  S. Hills,et al.  Interim Guidance for Interpretation of Zika Virus Antibody Test Results. , 2016, MMWR. Morbidity and mortality weekly report.

[18]  S. Rasmussen,et al.  Zika Virus and Birth Defects--Reviewing the Evidence for Causality. , 2016, The New England journal of medicine.

[19]  Emmanuel Fournier,et al.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study , 2016, The Lancet.

[20]  D. Musso,et al.  Potential Sexual Transmission of Zika Virus , 2015, Emerging infectious diseases.

[21]  A. Niemz,et al.  Diagnosis and Management of Hepatitis C Virus Infection , 2015, Journal of laboratory automation.

[22]  Myrielle Dupont-Rouzeyrol,et al.  Detection of Zika Virus in Urine , 2015, Emerging infectious diseases.

[23]  Brian D. Foy,et al.  Probable Non–Vector-borne Transmission of Zika Virus, Colorado, USA , 2011, Emerging infectious diseases.

[24]  R. Lanciotti,et al.  Zika virus outbreak on Yap Island, Federated States of Micronesia. , 2009, The New England journal of medicine.

[25]  I. Ishida,et al.  Antigen-specific human polyclonal antibodies from hyperimmunized cattle , 2009, Nature Biotechnology.

[26]  R. Lanciotti,et al.  Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.

[27]  A. Heath,et al.  Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine. , 2004, Biologicals : journal of the International Association of Biological Standardization.

[28]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[29]  Denise A. Martin,et al.  Standardization of Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assays for Routine Diagnosis of Arboviral Infections , 2000, Journal of Clinical Microbiology.

[30]  G. Dick,et al.  Zika virus. I. Isolations and serological specificity. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  G. Dick,et al.  Zika virus. II. Pathogenicity and physical properties. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  J. Muñoz-Jordán,et al.  Persistence of Zika Virus in Body Fluids — Preliminary Report , 2017 .

[33]  E. Postnikova,et al.  WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus , 2016 .